Despite the lack of deep value, there is something else: Aclaris Therapeutics Inc (ACRS) Stock
H.C. Wainwright raised the price target for the Aclaris Therapeutics Inc (NASDAQ:ACRS) stock from “a Buy” to “a Neutral”. The rating was released on January 22, 2024, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $22. The stock was initiated by Stifel, […]
A good growth outlook is seen for Aclaris Therapeutics Inc (ACRS) Stock by analysts
H.C. Wainwright raised the price target for the Aclaris Therapeutics Inc (NASDAQ:ACRS) stock from “a Buy” to “a Neutral”. The rating was released on January 22, 2024, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $22. The stock was initiated by Stifel, […]
Faced with a depressed economy, Aclaris Therapeutics Inc (ACRS) Stock offers an opportunity
H.C. Wainwright raised the price target for the Aclaris Therapeutics Inc (NASDAQ:ACRS) stock from “a Buy” to “a Neutral”. The rating was released on January 22, 2024, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $22. The stock was initiated by Stifel, […]
Why Aclaris Therapeutics Inc (NASDAQ:ACRS) Stock fell -77.07% in Last Six Months?
H.C. Wainwright raised the price target for the Aclaris Therapeutics Inc (NASDAQ:ACRS) stock from “a Buy” to “a Neutral”. The rating was released on January 22, 2024, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $22. The stock was initiated by Stifel, […]
Is Aclaris Therapeutics Inc (ACRS) Stock A Better Investment Than Its Rivals?
H.C. Wainwright raised the price target for the Aclaris Therapeutics Inc (NASDAQ:ACRS) stock from “a Buy” to “a Neutral”. The rating was released on January 22, 2024, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $22. The stock was initiated by Stifel, […]
What do you think? Take A Moment To Read: Aclaris Therapeutics Inc (ACRS) Stock
H.C. Wainwright raised the price target for the Aclaris Therapeutics Inc (NASDAQ:ACRS) stock from “a Buy” to “a Neutral”. The rating was released on January 22, 2024, according to finviz. The research report from Evercore ISI has initiated the stock to Outperform, with a price target set at $22. The stock was initiated by Stifel, […]
